Stockscreener 앱 받기
0.3439
1.75%
0.0059
시간 외 거래:
.34
-0.0039
-1.13%
전일 마감가:
$0.338
열려 있는:
$0.3352
하루 거래량:
376.12K
Relative Volume:
0.24
시가총액:
$48.25M
수익:
$121.91M
순이익/손실:
$1.83M
주가수익비율:
31.55
EPS:
0.0109
순현금흐름:
$7.75M
1주 성능:
-13.07%
1개월 성능:
-22.89%
6개월 성능:
-44.35%
1년 성능:
-44.53%
1일 변동 폭
$0.32
$0.3583
1주일 범위
$0.32
$0.4081
52주 변동 폭
$0.2702
$0.95
엑스탄트 Stock (XTNT) Company Profile
명칭
Xtant Medical Holdings Inc
전화
406-388-0480
주소
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.3439 | 47.42M | 121.91M | 1.83M | 7.75M | 0.0109 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
엑스탄트 Stock (XTNT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-05 | 개시 | BTIG Research | Buy |
| 2018-11-15 | 재확인 | Maxim Group | Buy |
| 2018-02-14 | 재확인 | Maxim Group | Buy |
엑스탄트 주식(XTNT)의 최신 뉴스
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference - Eastern Progress
XTNT stock focus shifts to latest medical device results and valuation - ad-hoc-news.de
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com South Africa
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market - TechStock²
XTNT SEC FilingsXtant Medical Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Nigeria
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - PR Newswire
BioHorizons will exclusively sell Xtant’s growth factor in the U.S. and Canada - Stock Titan
Xtant Medical Earnings Call: Growth Bets Amid Setbacks - TipRanks
ETFs Investing in Xtant Medical Holdings, Inc. Stocks - TradingView
Xtant (XTNT) Financial Results: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Move - vinanet.vn
Xtant Medical (XTNT) insider reports new stock transaction - Stock Titan
Xtant Medical (XTNT) insider updates SEC on stock transaction - Stock Titan
Xtant Medical (XTNT) grants COO 450K DSUs vesting 2027–30 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT) - The Globe and Mail
Xtant Medical Q2 2026 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... - Yahoo Finance
XTNT: Expanded sales force, new products, and asset sales drive growth and cash generation outlook - TradingView
Xtant Medical Holdings Releases Q2 2026 Financial Results - AlphaStreet
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Xtant Medical Cuts 2026 Revenue Guidance After Weak Biologics Sales and Amnio Headwinds - Minichart
Xtant Medical Holdings, Inc. (XTNT) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com South Africa
XTNT: Revenue and margins fell sharply, with a net loss and heightened supply chain risks - TradingView
Xtant Medical (XTNT) revenue drops 35% and turns to loss on divestitures, Dilon charge - Stock Titan
Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract - TradingKey
Xtant Medical Q2 Revenue Falls To $23.0 Million - Quiver Quantitative
XTNT: Q2 2026 saw revenue drop, margin compression, and a net loss, prompting lower full-year guidance - tradingview.com
Xtant Medical Holdings, Inc. Lowers Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Xtant Medical Holdings (XTNT) Plunges 28% to $0.32 as Selling Pressure MountsIchimoku TK Cross - siam.in
XTNT Q1 2026 Earnings: EPS Misses Estimates, Shares Slip 0.09Earnings Acceleration Picks - vinanet.vn
Xtant Medical Stockholders Approve Governance and Leadership Items - TipRanks
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026 - Morningstar
Xtant Medical Executives Will Host Q2 Results Call Aug. 11 - Stock Titan
Xtant Medical (XTNT) Posts Modest Gain, Holds Support at $0.42 Amid Rangebound TradingForce Index - vinanet.vn
XTNT Q1 2026 Earnings: Wider-Than-Expected Loss Triggers Modest Share DeclineEarnings Per Share - vinanet.vn
Xtant Medical (XTNT) Expected to Release Quarterly Earnings on Monday - MarketBeat
Xtant Medical Holdings, Inc. Revenue Breakdown – AMEX:XTNT - TradingView
Xtant Medical Holdings Inc (XTNT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.003 - TradingKey
TradingKey - TradingKey
Xtant Medical Holdings Inc (XTNT) Cash Flow - TradingKey
Xtant Medical Holdings Inc (XTNT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.001 - TradingKey
Xtant Medical Holdings Inc (XTNT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xtant Medical (XTNT) Consolidates Near $0.43 with Minimal MovementWave Extension - vinanet.vn
Xtant Medical Holdings (XTNT) Edges Higher as Key Levels TestedAAII Neutral - vinanet.vn
XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Modest Stock GainProfitability Analysis - vinanet.vn
XTNT stock trades around recent lows as Xtant Medical revenue climbs and losses narrow - Ad-hoc-news.de
SemiLEDs And 2 Other Promising Penny Stocks To Watch - simplywall.st
엑스탄트 (XTNT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.29%
0.75%
자본화:
|
볼륨(24시간):